Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Ketogenesis
53%
Liver
50%
Psychedelic Treatments
42%
Hepatic Gluconeogenesis
31%
Psychedelics
30%
Hepatic Ketogenesis
29%
Psychological Support
24%
Ketogenic
24%
Executive Function
24%
Functional Outcome
24%
Lipidome
24%
Fatty Liver Injury
24%
Older Adults
24%
Glycogen Metabolism
24%
Engagement Strategies
24%
Hepatic Glycogen
24%
Hyperglycemia
24%
Diet-induced
24%
Provider Perspectives
24%
Psychedelic Renaissance
24%
Psychedelic Drugs
24%
Free Response
24%
Clinical Trials
24%
21st Century
24%
Psychedelic-assisted Therapy
24%
Media Representation
24%
Inpatient Treatment
24%
Artificial Intelligence
24%
Tricarboxylic Acid Cycle (TCA cycle)
23%
Non-alcoholic Fatty Liver Disease (NAFLD)
21%
Hepatic Glucose Production
19%
Medical Rehabilitation
19%
Functional Improvement
19%
Fed State
19%
High-fat Diet
18%
Knock
14%
Anonymous Survey
12%
US States
12%
Serious Mental Illness
12%
Therapeutic Potential
12%
Dysphoria
12%
Clinical Report
12%
Sentiment Score
12%
Improved Outcomes
12%
Treatment Sessions
12%
Prior Trauma
12%
Clinical Practice Guidelines
12%
Psilocybin
12%
During Treatment
12%
Personal Contact
12%
Biochemistry, Genetics and Molecular Biology
Gluconeogenesis
100%
Ketogenesis
97%
Peroxisome Proliferator-Activated Receptor
32%
Homeostasis
32%
Lipid
24%
Adipocyte
24%
Adipokine
24%
Glycogen Liver Level
24%
Glycogen Metabolism
24%
Hyperglycemia
24%
Lipidome
24%
Ketone Bodies
24%
Deficiency
24%
Carbohydrates
21%
Citric Acid Cycle
20%
Transferase
16%
Enzyme
13%
Glucose
13%
Glucose Metabolism
12%
Glucose Blood Level
11%
Glycemia
11%
Fate Mapping
10%
Synthase
10%
Hepatocyte
8%
Energy Charge
8%
Knockout Mouse
8%
Caprylic Acid
8%
Phosphoenolpyruvate Carboxykinase
8%
Succinyl-CoA
8%
Pyruvate Carboxylase
8%
Skeletal Muscle
8%
Beta Oxidation
8%
Loss of Function Mutation
8%
Glucose 6-Phosphatase
8%
Mouse Model
8%
Acetyl-CoA
8%
Bioenergetics
8%
Alanine
8%
Acyl-CoA
6%
Metabolic Pathway
6%
Glycerol
5%